trending Market Intelligence /marketintelligence/en/news-insights/trending/dvfrnsqyiksohgzj-4egnw2 content esgSubNav
In This List

Auris regains compliance with one Nasdaq listing requirement

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Auris regains compliance with one Nasdaq listing requirement

Switzerland's Auris Medical Holding AG regained compliance with Nasdaq's minimum bid price requirement of $1 per share.

However, the pharmaceuticals company is yet to regain compliance with the stock exchange's minimum $35 million market value of listed securities.

Auris has until July 10 to regain compliance with that condition.